The effects of raloxifene and tibolone on homocysteine and vascular histopathological changes

KISA, Ucler/0000-0002-8131-6810; OZKAN, YESIM/0000-0002-1669-4962WOS: 000251961900004PubMed: 18188527The aim of the present study was to examine the effects of raloxifene (RLX) and tibolone (TBN) on plasma homocysteine (Hey) levels and their relationship with atherosclerotic changes in the walls of the carotid artery in ovariectomised rats. Thirty surgically ovariectomised Wistar albino rats after a menopausal period of 6 cycles were randomly assigned to receive RLX 0.01 mg/kg/day (n=10), TBN 0.04 mg/kg/day (n=10) and the same dose of placebo (n=10) for 6 cycles. Serum levels of vitamin B12, folate and Hey were measured and carotid arteries were examined histopathologically following the termination of treatment. Hey levels were 3.27 +/- 0.97, 2.57 +/- 0.32 and 2.28 +/- 0.12 mu mol/l, Vitamin B12 levels were 901.90 +/- 239.76, 694.70 +/- 112.20 and 631 +/- 309.44 pg/ml and folate levels were 73.80 +/- 12.71, 72.51 +/- 7.05 and 84.79 +/- 20.82 ng/ml in receiving RLX, TBN and placebo respectively. Hey levels were increased by RLX vs. placebo (P=0.006) but not by TBN vs. placebo (P=0.070). Vitamin B 12 levels were found to be elevated by TBN vs. the control group (P=0.041) but not by RLX vs. placebo (P=0.059). Histopathological examination of carotid arteries from rats receiving both RLX and TBN revealed no difference vs. placebo. Data obtained from the study support the view that neither RLX nor TBN appears to have a primary protective effect on vascular disease by effecting the metabolism of Hey at menopause